We're currently onboarding companies. Sign up to see when investments go live.
Pending Closing Since September 28, 2020
Ultrasonic Medical Mapping (Reg CF)

Developer of low cost, radiation-free cancer detection technology

Amount Raised




Days Left


The Company has subscriptions of $14,902 through its concurrent Regulation D offering page. This securities offering is filed with the Securities and Exchange Commission (the “SEC”). The official filing and all updates, may be obtained both here and on this offering's "Data Room" page. These statements reflect management's current views with respect to future events based on information currently available and are subject to risk factors that could cause actual results to differ materially. Investors are cautioned to not rely on these forward-looking statements as they do not represent guarantees of future results or performance, which cannot be made. No person or entity assumes responsibility for the accuracy and completeness of forward-looking statements, and is under no duty to update any such statements to conform them to actual results, except as required by the applicable law, regulations or rules. There are further risks factors mentioned in the Prospectus. There is a risk of loss of the entire investment. There is no guarantee of any specific outcome. Past performance is not indicative of future results.